Yoshinori Igarashi

Yoshinori Igarashi

Auto-generated profile, based on publicly available information

Yoshinori Igarashi

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Toho University Omori Medical Center, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2021 in Clinical Endoscopy
Verified
Journal Article
Open access
PDF file
NONaoki Okano
Naoki Okano
YIYoshinori Igarashi
Yoshinori Igarashi
KIKen Ito
Ken Ito
SMSaori Mizutani
Saori Mizutani
HNHiroki Nakagawa
Hiroki Nakagawa
YKYuui Kishimoto
Yuui Kishimoto
Background/Aims: Bleeding is a complication of endoscopic snare papillectomy for ampullary tumors. This study aimed to investigate the clinical efficacy of hypertonic saline-epinephrine (HSE) local injection before endoscopic papillectomy for prevention of bleeding.Methods: We retrospectively reviewed the data of 107 consecutive patients with ampullary tumors who underwent endoscopic papillectomy. The rates of en bloc resection, pathological resection margins, and prevention of immediate or delayed bleeding in the simple snaring resection group (Group A) and the HSE injection group (Group B) were compared.Results: A total of 44 and 63 patients were enrolled in Groups A and B, respectively. The total complete resection rate was 89.7% (96/107); the clinical complete resection rates in Group A and Group B were 86.3% (38/44) and 92.1% (58/63), respectively (p=0.354). Post-papillectomy bleeding occurred in 22 patients. In Groups A and B, the immediate bleeding rates were 20.5% (9/44) and 4.8% (3/63), respectively (p=0.0255), while the delayed bleeding rates were 7% (3/44) and 11% (7/63), respectively (p=0.52). The rates of positive horizontal and vertical pathological margin in both groups were 27% and 16%, respectively.Conclusions: HSE local injection was effective in preventing immediate bleeding and was useful for safely performing endoscopic papillectomy for ampullary tumors.

7 November 2013 in Oncology Letters
Verified
Journal Article
Open access
PDF file
KSKazue Shiozawa
Kazue Shiozawa
MWManabu Watanabe
Manabu Watanabe
TITakashi Ikehara
Takashi Ikehara
YMYasushi Matsukiyo
Yasushi Matsukiyo
MKMichio Kogame
Michio Kogame
YSYasukiyo Sumino
Yasukiyo Sumino
Hepatocellular carcinoma (HCC) is the third most common cause of cancer‑associated mortality worldwide. No effective treatment has been established for unresectable advanced HCC, and the prognosis is poor. Sorafenib is an oral multi‑targeted tyrosine kinase inhibitor for unresectable advanced HCC that significantly improves progression‑free and overall survival. However, in the two large phase III clinical trials (the SHARP and Asia‑Pacific trials), no cases of complete response (CR) were reported. The present study reports the case of a 68‑year‑old male with hepatitis C virus‑related cirrhosis and multiple recurrent HCCs, with a tumor thrombus of the third portal vein following resection. The patient received 400 mg once daily (half the standard dose) of sorafenib for two years and achieved a CR. At the most recent follow‑up examination at one year after the cessation of treatment, the patient was observed to be in remission without clinical or imaging evidence of disease recurrence.

13 December 2022 in Gut and Liver
Verified
Journal Article
Open access
PDF file
KIKen Ito
Ken Ito
NONaoki Okano
Naoki Okano
KTKensuke Takuma
Kensuke Takuma
SISusumu Iwasaki
Susumu Iwasaki
KWKoji Watanabe
Koji Watanabe
YIYoshinori Igarashi
Yoshinori Igarashi
Ken Ito, Naoki Okano, Kensuke Takuma, Susumu Iwasaki, Koji Watanabe, Yusuke Kimura, Yuto Yamada, Kensuke Yoshimoto, Seiichi Hara, Yui Kishimoto, Takahisa Matsuda, and Yoshinori Igarashi. Gut and Liver -0001;0:. https://doi.org/10.5009/gnl220204

19 July 2021 in International Cancer Conference Journal
Verified
Journal Article
Open access
PDF file
YKYoshinori Kikuchi
Yoshinori Kikuchi
HSHideaki Shimada
Hideaki Shimada
KIKazutoshi Isobe
Kazutoshi Isobe
RSRyo Shimizu
Ryo Shimizu
MWMunehiro Wakabayashi
Munehiro Wakabayashi
YIYoshinori Igarashi
Yoshinori Igarashi
Since colorectal metastases from primary lung cancer are rare, the location of metastatic lesion and prognostic factors have not been well evaluated. Therefore, we carried out a systematic review and meta-analysis to assess the clinicopathological characteristics and prognostic factors of Japanese patients with colorectal metastasis from lung cancer. We searched the Ichushi-Web database from January 1964 to December 2020. We found 59 colorectal metastases in 52 cases for this meta-analysis. Small cell carcinoma was shown to have significantly more metastases to the appendix than non-small cell carcinoma. However, there was no significant correlation between location and histology when classified into right and left colons (P = 0.247). The median overall survival after diagnosis was 6 months. Univariate analysis showed that adenocarcinoma (Hazard Ratio (HR) 0.383, P = 0.024), simultaneous metastasis (HR 0.325, P = 0.046), and chemotherapy group (HR 0.482, P = 0.044) were good prognostic factors. Multivariate analysis confirmed that chemotherapy (HR 0.38, P = 0.02) was an independent good prognostic factor for overall survival. In conclusion, although there was no statistical difference, right colon metastases were more frequent than left colon metastases. Chemotherapy may be effective for colorectal metastases from lung cancer.

16 April 2022 in Clinical Journal of Gastroenterology
Verified
Journal Article
Open access
PDF file
TMTeppei Matsui
Teppei Matsui
HNHidenari Nagai
Hidenari Nagai
MAMakoto Amanuma
Makoto Amanuma
KKKojiro Kobayashi
Kojiro Kobayashi
YOYu Ogino
Yu Ogino
YIYoshinori Igarashi
Yoshinori Igarashi
Left-side portal hypertension (LSPH) is caused by isolated obstruction of the splenic vein and is associated with esophagogastric varices that extend from the lower esophagus to the greater curvature of the gastric body. Here, we report on a 74-year-old man with a pancreatic neuroendocrine neoplasm (NEN) in the pancreatic tail with multiple liver metastases. We decided that partial splenic embolization (PSE) was the best course of treatment to prevent rupture of the gastric varices, which were classified as markedly enlarged, nodular, or tumor-shaped and showed erosion of the mucosa. After PSE, the patient had no major complications and was discharged. At 3 and 6 months after the procedure, esophagogastroduodenoscopy and enhanced computerized tomography showed that the gastric varices had improved. This case demonstrates the usefulness of PSE for LSPH in patients with unresected pancreatic NEN.

1 January 1993 in Progress of Digestive Endoscopy(1972)
Verified
Journal Article
Open access
NJNobuhiko Jyoki
Nobuhiko Jyoki
SNShunichi Nakajima
Shunichi Nakajima
SMShuuji Matsumura
Shuuji Matsumura
CYChikako Yasuda
Chikako Yasuda
HIHirokazu Inoue
Hirokazu Inoue
MWMegumi Wakayama
Megumi Wakayama